SARS-CoV-2 (COVID-19) Omicron Variant (B.1.1.529) Nucleocapsid Recombinant Protein | 21-850

SARS-CoV-2 (COVID-19) Omicron Variant (B.1.1.529) Nucleocapsid Recombinant Protein | 21-850 | Gentaur UK, US & Europe Distribution

Tested Application: N/A

Application: Immunogen

Tpredicted Molecular Weight: 46.31 kDa

Physical State: Lyophilized

Buffer: Supplied as solution form in PBS, pH7.5 or lyophilized from PBS, pH7.5

Storage Condition: Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚C for one week . Store at -20 to -80 ˚C for twelve months from the date of receipt.

Alternate Name: 2019-nCoV coronavirus NP Protein; 2019-nCoV np Protein; 2019-nCoV novel coronavirus Nucleoprotein Protein

Background: N/A

Shipping: N/A

Disclaimer: Products are intended for laboratory research purposes only and should be used by qualified personnel only. They are not intended for use in humans. ProSci is not liable for damages or injuries resulting from receipt and/or use of ProSci materials. Please refer to the Material Safety Data Sheet (MSDS) for safe storage, handling, and use procedures.

Source: E. coli

Species: SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleocapsid protein

By Source: E. Coli

By Species: Other

Fusion Tag: N-His Tag

Sequence: SARS-CoV-2 Nucleocapsid (YP_009724397.2, with mutations P13L, ERS31-33 deletion, R203K, G204R) (Met1-Ala419)

Bological Activity: N/A

Purity: >90% as determined by SDS-PAGE